# Erzofri extended-release

NDC: 72526-110
Generic name: paliperidone palmitate
Labeler / Manufacturer: Shandong Luye Pharmaceutical Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20241210

FDA application: NDA216352

## Active ingredients

- PALIPERIDONE PALMITATE: 351 mg/2.25mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72526-110"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72526-110
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=492bf9dd-868e-421a-92db-8cca8973aac1